Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Immunotherapy tackles lupus

Dysregulation of T cells and B cells occurs in lupus and other autoimmune diseases. A monoclonal antibody therapy that seems to activate T cells restores some balance in a mouse model of lupus (pages 1405–1413).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Anti-CD137 immunotherapy in a mouse model of lupus.

References

  1. Sun, Y. et al. Therapeutic treatment of a spontaneous autoimmune disease with an agonistic monoclonal antibody against a costimulatory molecule. Nature Med. 8, 1405–1413 (2002).

    Article  CAS  Google Scholar 

  2. Shlomchik, M.J., Craft, J.E. & Mamula, M.J. From T to B and back again: Positive feedback in systemic autoimmune disease. Nature Rev. Immunol. 1, 147–153 (2001).

    Article  CAS  Google Scholar 

  3. Kammer, G.M., Perl, A., Richardson, B.C. & Tsokos, G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46, 1139–1154 (2002).

    Article  CAS  Google Scholar 

  4. Oates, J.C. & Gilkeson, G.S. Mediators of injury in lupus nephritis. Curr. Opin. Rheumatol. 14, 498–503 (2002).

    Article  CAS  Google Scholar 

  5. Sica, G. & Chen, L. Modulation of the immune response through 4-1BB. Adv. Exp. Med. Biol. 465, 355–362 (2000).

    Article  CAS  Google Scholar 

  6. Ye, Z. et al. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nature Med. 8, 343–348 (2002).

    Article  CAS  Google Scholar 

  7. Halstead, E.S., Mueller, Y.M., Altman, J.D. & Katskikis, P.D. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nature Immunol. 3, 536–541 (2002).

    Article  CAS  Google Scholar 

  8. Balomenos, D., Rumold, R. & Theofilopoulos, A.N. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101, 364–371 (1998).

    Article  CAS  Google Scholar 

  9. Nicoletti, F. et al. Dichotomic effects of IFN-γ on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur. J. Immunol. 30, 438–447 (2000).

    Article  CAS  Google Scholar 

  10. Seo, S., Mandik-Nayak, L. & Erikson, J. B cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6, 1–20 (2003).

    PubMed  Google Scholar 

  11. Gescuk, B.D. & Davis, J.C. Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr. Opin. Rheumatol. 14, 515–521 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kammer, G. Immunotherapy tackles lupus. Nat Med 8, 1356–1358 (2002). https://doi.org/10.1038/nm1202-1356

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1202-1356

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing